Authors and Affiliates
Vania Hungria, Paweł Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, P Joy Ho, Roman Hájek, Kihyun Kim, Sebastian Grosicki,
Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Aparecida Martinez, Anna Sureda Balarí, Irwindeep Sandhu,
Claudio Cerchione, Peter Ganly, Meletios A Dimopoulos, Chengcheng Fu, Mamta Garg, Al-Ola Abdallah, Moshe E Gatt,
Albert Oriol Rocafiguera, Michele Cavo, Robert Rifkin, Tomoaki Fujisaki, Michał Mielnik, Joseph Ficek, Alejandro Mantero, Nick Pirooz,
Sybil Varghese, Joe Lee, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy-Ghanta, Pralay Mukhopadhyay,
Jacqueline Nielsen, Joanna Opalinska, María-Victoria Mateos, on behalf of the DREAMM-7 study investigators
Clinica São Germano, São
Paulo, Brazil (V Hungria MD);
Medical University of Łódź,
Łódź, Poland (Prof P Robak MD);
Samodzielny Publiczny Szpital
Kliniczny, Lublin, Poland
(Prof M Hus MD, M Mielnik MD);
Gorodskaya Klinicheskaya
Bol’nitsa Im Sp Botkina,
Moscow, Russia
(V Zherebtsova MD); Royal
North Shore Hospital, Sydney,
NSW, Australia
(Prof C Ward MD); Royal Prince
Alfred Hospital, Camperdown,
NSW, Australia
(Prof P J Ho MBBS); University
Hospital Ostrava and
University of Ostrava, Ostrava,
Czech Republic
(Prof R Hájek MD);
Sungkyunkwan University,
Samsung Medical Center,
Seoul, South Korea
(Prof K Kim MD); Medical
University of Silesia, Katowice,
Poland (Prof S Grosicki MD);
Pindara Private Hospital, Gold
Coast, QLD, Australia
(H Sia MBBS); Liverpool
Hospital, Sydney, NSW,
Australia (A Bryant PhD);
Universidade da Região de
Joinville and Centro de
Hematologia e Oncologia,
Joinville, Santa Catarina, Brazil
(Prof M Pitombeira de Lacerda
MD); Hospital das Clínicas and
Instituto do Câncer do Estado
de São Paulo, Universidade de
São Paulo, São Paulo, Brazil
(G A Martinez MD); Institut
Català d’Oncologia-
L’Hospitalet L.-Barcelona,
Barcelona, Spain
(A Sureda Balarí MD); Cross
Cancer Institute, Edmonton,
AB, Canada (I Sandhu MD);
Hematology Unit, Istituto
Romagnolo per lo Studio dei
Tumori “Dino Amadori” - IRST
IRCCS, Meldola, Forlì-Cesena,
Italy (C Cerchione MD);
Christchurch Hospital,
Christchurch, New Zealand
(P Ganly PhD); School of
Medicine, National and
Kapodistrian University of
Athens, Athens, Greece
(Prof M A Dimopoulos MD);
Korea University, Seoul,
South Korea
(Prof M A Dimopoulos); The
First Affiliated Hospital of
Soochow University, Jiangsu,
China (Prof C Fu MD); University
Hospitals of Leicester NHS
Trust, Leicester, UK
(M Garg MD); University of
Kansas Cancer Center, Fairway,
KS, USA (A-O Abdallah MD);
Department of Haematology,
Hadassah Medical Center,
Faculty of Medicine, Hebrew
University of Jerusalem,
Jerusalem, Israel (M E Gatt MD);
Institut Català d’Oncologia and
Josep Carreras Research
Institute, Hospital Germans
Trias i Pujol, Badalona, Spain
(A Oriol Rocafiguera MD);
Department of Medical and
Surgical Sciences, University of
Bologna, Bologna, Italy
(Prof M Cavo MD); Rocky
Mountain Cancer Centers—
Denver—Midtown, Denver, CO,
USA (R Rifkin MD); Matsuyama
Red Cross Hospital,
Matsuyama, Japan
(T Fujisaki MD); GSK,
Collegeville, PA, USA
(J Ficek PhD, A Mantero PhD,
N Pirooz MHA, S Varghese MBBS,
R Rogers MS, S Roy-Ghanta MD,
P Mukhopadhyay PhD,
J Opalinska MD); GSK, London,
UK (J Lee PhD, L Eccersley PhD);
GSK, Stevenage, UK
(A McKeown PhD); GSK,
Mississauga, ON, Canada
(H Baig BS); GSK, Chicago, IL,
USA (J Nielsen PhD); Instituto
de Investigación Biomédica de
Salamanca, Hospital
Universitario de Salamanca–
IBSAL–CIC–Ciberonc,
Salamanca, Spain
(M-V Mateos MD)
